Pierre Fabre Laboratories is the second largest independent pharmaceutical group in France with revenue of over 3 billion CAD in 2014, 56% of which comes from international business. Pierre Fabre is present in 44 countries and its products are distributed in more than 130 countries.
Through its two divisions, Pierre Fabre Pharmaceuticals and Pierre Fabre Dermo-Cosmétique, Pierre Fabre’s activities cover all areas of healthcare from prescription and OTC drugs to dermo-cosmetic treatments. Pierre Fabre has 10,000 employees around the world, including 1,200 in R&D where over 10% of its turnover is invested. With its well-known brands such as Eau Thermale Avène, A-Derma, Ducray, Klorane, René Furterer and Elancyl, Pierre Fabre Dermo-Cosmétique is Europe’s market leading dermo-cosmetics laboratory. In pharmaceutics, Pierre Fabre focuses on three therapeutic area: Oncology, CNS, and Dermatology.
Pierre Fabre Dermo-Cosmétique, a leading Dermo-Cosmetic company in Canada, is developing a new therapy for the treatment of Infantile Hemangiomas. Recently, the Dermatology Business Unit was formed to launch a new franchise in the pediatric–dermatology category.